CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding CytomX Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 119 | 2 | 99 | −18 |
| Shares | 53.7M | 34.6K | 45.6M | −8.08M (−15.1%) |
| Value | $143.4M | $92.0K | $83.4M | −$59.8M (−41.8%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held CytomX Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 1,270,900 | $2.33M | 0.10% |
| Newtyn Management, LLC | 1,073,400 | $1.96M | 0.37% |
| Tang Capital Management LLC | 1,054,673 | $1.93M | 0.29% |
| Oasis Management Co Ltd. | 540,541 | $989.0K | 0.18% |
| AQR Capital Management LLC | 391,860 | $717.0K | 0.00% |
| Ergoteles LLC | 318,000 | $582.0K | 0.02% |
| Formidable Asset Management, LLC | 207,772 | $380.0K | 0.09% |
| Toroso Investments, LLC | 207,772 | $380.0K | 0.01% |
| Knightsbridge Asset Management, LLC | 96,926 | $177.0K | 0.04% |
| Cornercap Investment Counsel Inc | 78,452 | $144.0K | 0.02% |
| Qube Research & Technologies Ltd | 55,846 | $102.0K | 0.00% |
| Man Group plc | – | $68.0K | 0.00% |
| LPL Financial LLC | 34,740 | $64.0K | 0.00% |
| Algert Global LLC | 30,340 | $56.0K | 0.00% |
| State of Wyoming | 23,709 | $43.0K | 0.03% |
| LMR Partners LLP | 23,134 | $42.0K | 0.00% |
| Prudential Financial Inc | 19,700 | $36.0K | 0.00% |
| Balyasny Asset Management LLC | 16,552 | $30.0K | 0.00% |
| Gladius Capital Management LP | 13,172 | $25.0K | 0.01% |
| Occudo Quantitative Strategies LP | 10,808 | $20.0K | 0.00% |
| Leonteq Securities AG | 6,000 | $11.0K | 0.00% |
| Credit Suisse AG | 35 | $0 | 0.00% |
Sold out (40)
Institutions that held CytomX Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held CytomX Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 24,371 | $65.0K |
| Amalgamated Financial Corp. | 10,184 | $27.0K |